Clinical Trials · NCT07621640
Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Hallym University
- Enrollment
- 80
- Start date
- Jun 2026
- Locations
- 2 sites, South Korea
- Primary endpoint
- Correlation between baseline BAT metabolic activity (SUVmean and BAT volume on ¹⁸FDG-PET/CT) and percentage body weight loss at 24 weeks of semaglutide treatment